Literature DB >> 34127497

Loss of SDHB Promotes Dysregulated Iron Homeostasis, Oxidative Stress, and Sensitivity to Ascorbate.

Sophie Moog1,2, Aurélie Morin1,2, Judith Goncalves1,2, Géraldine Gentric3, Sebastian Müller4, Alexander P Morrell5, Katarina Kluckova6, Theodora J Stewart7, Cynthia L Andoniadou8, Charlotte Lussey-Lepoutre1,9, Paule Bénit10, Alpesh Thakker6, Lisa Vettore6, Jennie Roberts6, Raphaël Rodriguez4, Fatima Mechta-Grigoriou3, Anne-Paule Gimenez-Roqueplo1,2,11, Eric Letouzé12, Daniel A Tennant6, Judith Favier13,2.   

Abstract

Succinate dehydrogenase is a key enzyme in the tricarboxylic acid cycle and the electron transport chain. All four subunits of succinate dehydrogenase are tumor suppressor genes predisposing to paraganglioma, but only mutations in the SDHB subunit are associated with increased risk of metastasis. Here we generated an Sdhd knockout chromaffin cell line and compared it with Sdhb-deficient cells. Both cell types exhibited similar SDH loss of function, metabolic adaptation, and succinate accumulation. In contrast, Sdhb-/- cells showed hallmarks of mesenchymal transition associated with increased DNA hypermethylation and a stronger pseudo-hypoxic phenotype compared with Sdhd-/- cells. Loss of SDHB specifically led to increased oxidative stress associated with dysregulated iron and copper homeostasis in the absence of NRF2 activation. High-dose ascorbate exacerbated the increase in mitochondrial reactive oxygen species, leading to cell death in Sdhb-/- cells. These data establish a mechanism linking oxidative stress to iron homeostasis that specifically occurs in Sdhb-deficient cells and may promote metastasis. They also highlight high-dose ascorbate as a promising therapeutic strategy for SDHB-related cancers. SIGNIFICANCE: Loss of different succinate dehydrogenase subunits can lead to different cell and tumor phenotypes, linking stronger 2-OG-dependent dioxygenases inhibition, iron overload, and ROS accumulation following SDHB mutation. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34127497     DOI: 10.1158/0008-5472.CAN-20-2936

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

Review 1.  Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer.

Authors:  Anja Karlstaedt; Javid Moslehi; Rudolf A de Boer
Journal:  Nat Rev Cardiol       Date:  2022-04-19       Impact factor: 32.419

2.  Phenazine derivatives attenuate the stemness of breast cancer cells through triggering ferroptosis.

Authors:  Yue Yang; Yuanyuan Lu; Chunhua Zhang; Qianqian Guo; Wenzhou Zhang; Ting Wang; Zhuolu Xia; Jing Liu; Xiangyu Cheng; Tao Xi; Feng Jiang; Lufeng Zheng
Journal:  Cell Mol Life Sci       Date:  2022-06-11       Impact factor: 9.207

Review 3.  Hypothesis: Why Different Types of SDH Gene Variants Cause Divergent Tumor Phenotypes.

Authors:  Jean-Pierre Bayley; Peter Devilee
Journal:  Genes (Basel)       Date:  2022-06-07       Impact factor: 4.141

4.  A suppressor of dioxygenase inhibition in a yeast model of SDH deficiency.

Authors:  William Beimers; Megan Braun; Kaleb Schwinefus; Keenan Pearson; Brandon Wilbanks; Louis James Maher
Journal:  Endocr Relat Cancer       Date:  2022-05-11       Impact factor: 5.900

5.  SDHB knockout and succinate accumulation are insufficient for tumorigenesis but dual SDHB/NF1 loss yields SDHx-like pheochromocytomas.

Authors:  Neali Armstrong; Claire M Storey; Sarah E Noll; Katherine Margulis; Myat Han Soe; Haixia Xu; Benjamin Yeh; Lauren Fishbein; Electron Kebebew; Brooke E Howitt; Richard N Zare; Julien Sage; Justin P Annes
Journal:  Cell Rep       Date:  2022-03-01       Impact factor: 9.995

6.  Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation.

Authors:  Takao Kamai; Satoshi Murakami; Kyoko Arai; Daisaku Nishihara; Toshitaka Uematsu; Kazuyuki Ishida; Toshiki Kijima
Journal:  BMC Cancer       Date:  2022-03-18       Impact factor: 4.430

Review 7.  The Relationship of Redox With Hallmarks of Cancer: The Importance of Homeostasis and Context.

Authors:  Faliang Xing; Qiangsheng Hu; Yi Qin; Jin Xu; Bo Zhang; Xianjun Yu; Wei Wang
Journal:  Front Oncol       Date:  2022-04-22       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.